日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Magnetostaltic pumping in an ex vivo extracorporeal membrane oxygenation model

体外膜肺氧合模型中的磁稳态泵

Zolala, Mohammadreza; Heim, Veronique; Denis, Cécile V; Lenting, Peter J; Mangin, Pierre H; Hermans, Thomas M

Modeling response to high-purity von Willebrand factor: toward tailored dosing during surgery in von Willebrand disease

对高纯度血管性血友病因子的反应建模:旨在为血管性血友病手术提供个体化给药方案

Daniel, Mélanie Y; Rauch, Antoine; Paris, Camille; Jeanpierre, Emmanuelle; Goudemand, Jenny; Marichez, Catherine; Pradines, Bénédicte; Zawadzki, Christophe; Dupont, Annabelle; Denis, Cécile V; Lenting, Peter J; Susen, Sophie; Delavenne, Xavier

Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9

利用 CRISPR/Cas9 技术对 2 型血管性血友病中的致病性 VWF 变异体进行等位基因选择性破坏

Bär, Isabel; Groten, Stijn A; Barraclough, Alastair; Bürgisser, Petra E; van Kwawegen, Calvin; Lenting, Peter J; van Moort, Iris; Eikenboom, Jeroen C J; Leebeek, Frank W G; Voorberg, Jan; van den Biggelaar, Maartje; Bierings, Ruben

Total thrombus formation system exploration of primary hemostasis in cirrhotic patients

肝硬化患者原发性止血全血栓形成系统探索

Abdoul, Johan; Luc, Norman; Joly, Bérangère S; Jehl, Antoine; Blandinières, Adeline; Adam, Frédéric; Duhaut, Léa; Aljhni, Rania; Grimaldi, Lamiae; Lenting, Peter J; Sen Gupta, Anirban; Denis, Cécile V; Roullet, Stéphanie

Nine areas with outstanding challenges for hemophilia B research

血友病B研究面临的九个突出挑战领域

Astermark, Jan; Hermans, Cédric; Lenting, Peter J; O'Donnell, James S

Orthostatic blood pressure changes among adults in Ekiti state, Nigeria: Impact of socio-demographic, anthropometric, and biophysical factors

尼日利亚埃基蒂州成年人体位性血压变化:社会人口学、人体测量学和生物物理因素的影响

Fabunmi, Oyesanmi A; Adeniyi, Mayowa J; Lenting, Andrea; Masilela, Thulani; Janse van Rensburg, Dina C Christa

A fully humanized von Willebrand disease type 1 mouse model as unique platform to investigate novel therapeutic options

一种完全人源化的 1 型血管性血友病小鼠模型,可作为研究新型治疗方案的独特平台

McCluskey, Genevieve; Heestermans, Marco; Peyron, Ivan; Pascal, Eloise; Clavel, Marie; Bun, Eric; Bocquet, Emilie; Reperant, Christelle; Susen, Sophie; Christophe, Olivier D; Denis, Cecile V; Lenting, Peter J; Casari, Caterina

Consistent clinical factor VIII equivalency is unlikely for non-factor therapies in hemophilic mice

在血友病小鼠中,非因子疗法不太可能达到一致的临床因子VIII等效疗效。

Sefiane, Thibaud; McCluskey, Geneviève; Clavel, Marie; Maynadié, Hortense; Peyron, Ivan; David, Tovo; Brochier, Camille; Saller, François; Khamari, Mariem; Denis, Cécile V; Christophe, Olivier D; Lenting, Peter J; Muczynski, Vincent; Casari, Caterina

Erratum to: "Consistent clinical factor VIII equivalency is unlikely for non-factor therapies in hemophilic mice"

更正:“对于血友病小鼠的非因子疗法而言,不太可能出现一致的临床因子VIII等效性”

Sefiane, Thibaud; McCluskey, Geneviève; Clavel, Marie; Maynadié, Hortense; Peyron, Ivan; David, Tovo; Brochier, Camille; Saller, François; Khamari, Mariem; Denis, Cécile V; Christophe, Olivier D; Lenting, Peter J; Muczynski, Vincent; Casari, Caterina

Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes

非重型血友病:亟需重新关注并改善治疗效果

Dolan, Gerard; Fijnvandraat, Karin; Lenting, Peter J; Catarino, Cristina; Lavin, Michelle